Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The slow inward sodium channel refers to a subset of voltage-gated sodium channels (Na_v) that exhibit incomplete or delayed inactivation, resulting in a persistent or "late" inward sodium current during the plateau phase of the action potential. These currents are particularly relevant in cardiac tissue but also play roles in neurons and other excitable cells. They contribute to action potential duration, diastolic depolarization, and can become pathologically increased in conditions like LQT3, heart failure, and angina, leading to arrhythmias. Certain antiarrhythmic drugs target these slow/persistent components to manage these conditions.
Blockade of sodium channels, preferential inhibition of late/persistent I_{Na}
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Slow Inward Sodium Channel.